UPDATE : Wednesday, June 19, 2019
상단여백
Seoul Medical Center to export public healthcare platform to Turkmenistan
Seoul Medical Center said Friday that it has signed an agreement to export ...
by Lee Han-soo  |  2019-04-19 17:48
라인
‘Darzalex as another weapon against multiple myeloma’
Janssen Korea’s Darzalex (ingredient: daratumumab) is effective for heavily...
by Park Gi-taek  |  2019-04-19 15:39
라인
Fine dust can increase risk of hypertension in people with abdominal obesity
Researchers at Seoul National University Hospital have found that fine dust...
by Lee Han-soo  |  2019-04-19 15:28
라인
Why is TissueGene CEO silent about Invossa mislabeling?
Noh Moon-jong, CEO of Kolon TissueGene, is the key person to clarify why In...
by Jeong Sae-im  |  2019-04-19 14:37
라인
[Special]‘K-Medi’s overseas advance will contribute to health of global citizens’
The Division of Global Health Care Affairs at the Ministry of Health and We...
by Kwak Sung-sun  |  2019-04-19 14:22
라인
JVM to supply pharmaceutical packaging machine to Russia
JVM, a subsidiary of Hanmi Pharmaceutical, said Friday that it has signed a...
by Lee Han-soo  |  2019-04-19 14:09
라인
Dong-A to export birth control pill to Vietnam
Dong-A Pharmaceutical said Friday it has agreed to export Roman K, a birth ...
by Lee Han-soo  |  2019-04-19 13:41
라인
Diabetic patients have higher risk of suffering from other illnesses
Researchers at Gangnam Severance Hospital have found that diabetes patients...
by Lee Han-soo  |  2019-04-18 16:02
라인
CJ HealthCare’s new gastric acid blocker K-Cab sold ₩ 1.5 billion in March
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded 1.53 bil...
by Jeong Sae-im  |  2019-04-18 15:27
라인
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
In the past, HIV and AIDS were known as deadly diseases that could take awa...
by Kim Yun-mi  |  2019-04-18 15:20
라인
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why?
Novartis’ new treatment for macular degeneration might have to fight agains...
by Kim Yun-mi  |  2019-04-18 14:42
라인
‘How Korean pharma companies can succeed in US’
With most Korean pharmaceutical and biosimilar companies aiming to launch t...
by Lee Han-soo  |  2019-04-18 14:41
라인
Kolon desperate to keep Invossa license amid suspicion of data fabrication
Kolon Life Science might get its sales license of Invossa-K revoked, as the...
by Lee Hye-seon  |  2019-04-18 11:16
라인
IVI-led consortium wins Fleming Fund's grant
An international consortium led by the International Vaccine Institute (IVI...
by Lee Han-soo  |  2019-04-18 11:15
라인
Severance Hospital succeeds in combined lung-liver transplant
Severance Hospital said Tuesday that it has successfully conducted a lung-l...
by Lee Han-soo  |  2019-04-17 18:00
라인
Small drugmakers celebrate export deals worth ₩18.3 billion
The Ministry of Health and Welfare and the Korea Health Industry Developmen...
by Kwak Sung-sun  |  2019-04-17 17:20
라인
THAAD backlash almost over: Chinese patients to Korea up 18 %
The number of Chinese patients visiting Korea rebounded in 2018, signaling ...
by Kwak Sung-sun  |  2019-04-17 16:00
라인
Patients to file class-action suit against Kolon over Invossa
Local patients who got Invossa-K injection for arthritis treatment will pur...
by Jeong Sae-im  |  2019-04-17 14:58
라인
‘Invossa lacked clinical evidence to be commercialized’
Kolon Life Science’s gene therapy Invossa-K for arthritis treatment had ina...
by Jeong Sae-im  |  2019-04-17 12:45
라인
Shinpoong’s acute ischemic stroke treatment wins government support
Shinpoong Pharmaceutical said Tuesday that the Ministry of Food and Drug Sa...
by Lee Han-soo  |  2019-04-17 12:42
여백
여백
여백
Back to Top